NKTR — NEKTAR THERAPEUTICS

Ownership history in Persistent Asset Partners Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which Persistent Asset Partners Ltd reported a position in NEKTAR THERAPEUTICS (NKTR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.68% (2025 Q3)
Avg. % of fund
0.28%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 17,270 +15,710 +1007.1% 0.68% $983K $56.90
2024 Q4 REDUCED 1,560 -165,012 -99.1% 0.06% $73K $13.95
2024 Q4 INITIATED 166,572 — — 0.11% $138K $13.95
% of Fund (quarterly)    NKTR price (monthly, adj. close)

Other funds also holding NKTR

As of 2025 Q4 — sorted by position size

22NW, LP 3Y 7Y 5.89% Prosight Management, LP 3Y 7Y 4.85% Propel Bio Management, LLC 2.99% GREAT POINT PARTNERS LLC 3Y 7Y 2.89% Stonepine Capital Management, LLC 3Y 7Y 2.62% Deuterium Capital Management, LLC 3Y 2.29% Monashee Investment Management LLC 3Y 7Y 2.24% BVF INC/IL 3Y 7Y 2.22% Stonepine Capital Management, LLC 3Y 7Y 1.54% STEMPOINT CAPITAL LP 1.29%
← Back to Persistent Asset Partners Ltd Holdings